Multiple environmental exposures in early-life and allergy-related outcomes in childhood.


Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
11 2020
Historique:
received: 05 03 2020
revised: 10 06 2020
accepted: 03 08 2020
pubmed: 28 8 2020
medline: 12 1 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

Early onset and high prevalence of allergic diseases result in high individual and socio-economic burdens. Several studies provide evidence for possible effects of environmental factors on allergic diseases, but these are mainly single-exposure studies. The exposome provides a novel holistic approach by simultaneously studying a large set of exposures. The aim of the study was to evaluate the association between a broad range of prenatal and childhood environmental exposures and allergy-related outcomes in children. Analyses of associations between 90 prenatal and 107 childhood exposures and allergy-related outcomes (last 12 months: rhinitis and itchy rash; ever: doctor-diagnosed eczema and food allergy) in 6-11 years old children (n = 1270) from the European Human Early-Life Exposome cohort were performed. Initially, we used an exposome-wide association study (ExWAS) considering the exposures independently, followed by a deletion-substitution-addition selection (DSA) algorithm considering all exposures simultaneously. All the exposure variables selected in the DSA were included in a final multi-exposure model using binomial general linear model (GLM). In ExWAS, no exposures were associated with the outcomes after correction for multiple comparison. In multi-exposure models for prenatal exposures, lower distance of residence to nearest road and higher di-iso-nonyl phthalate level were associated with increased risk of rhinitis, and particulate matter absorbance (PM This first comprehensive and systematic analysis of many environmental exposures suggests that prenatal exposure to traffic-related variables, PM

Identifiants

pubmed: 32854059
pii: S0160-4120(20)31993-0
doi: 10.1016/j.envint.2020.106038
pmc: PMC8768577
mid: NIHMS1759230
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106038

Subventions

Organisme : Medical Research Council
ID : MR/S037527/1
Pays : United Kingdom
Organisme : NIEHS NIH HHS
ID : P30 ES007048
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Références

Eur Respir J. 2007 May;29(5):879-88
pubmed: 17251230
Sci Total Environ. 2010 Sep 15;408(20):4403-11
pubmed: 20621332
Nicotine Tob Res. 2017 Jul 1;19(7):804-809
pubmed: 27794037
Environ Res. 2011 Nov;111(8):1222-9
pubmed: 21855059
Environ Health. 2017 Jul 14;16(1):74
pubmed: 28709428
PeerJ. 2013 Nov 07;1:e193
pubmed: 24255809
Environ Int. 2019 Feb;123:189-200
pubmed: 30530161
Allergol Immunopathol (Madr). 2013 Mar-Apr;41(2):73-85
pubmed: 22771150
Int J Epidemiol. 2012 Aug;41(4):930-40
pubmed: 21471022
Biomed Res Int. 2017;2017:4216107
pubmed: 29057259
Eur Respir Rev. 2016 Jun;25(140):124-9
pubmed: 27246588
Environ Health Perspect. 2014 Jun;122(6):535-44
pubmed: 24610234
Am J Respir Crit Care Med. 2008 Jun 15;177(12):1331-7
pubmed: 18337595
Int J Epidemiol. 2012 Feb;41(1):24-32
pubmed: 22296988
Environ Int. 2019 Apr;125:505-514
pubmed: 30583854
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Pediatr Allergy Immunol. 2008 Nov;19(7):580-6
pubmed: 18540992
Eur J Epidemiol. 2020 Mar;35(3):193-204
pubmed: 32221742
Thorax. 2007 Jan;62(1):91-6
pubmed: 16950836
Toxicology. 2010 May 27;271(3):73-82
pubmed: 20371260
Environ Sci Technol. 2014 Mar 18;48(6):3128-35
pubmed: 24559238
Environ Int. 2014 Jan;62:48-54
pubmed: 24161446
Eur Respir J. 2010 Jul;36(1):33-40
pubmed: 20075054
J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):125-38
pubmed: 9893196
Pediatr Allergy Immunol. 2014 Feb;25(1):43-50
pubmed: 24313809
Hum Genet. 2012 May;131(5):747-56
pubmed: 22143225
Allergy Asthma Proc. 2017 Jan 1;38(1):3-8
pubmed: 28052794
Environ Int. 2018 Dec;121(Pt 1):751-763
pubmed: 30326459
Sci Total Environ. 2018 Mar 15;618:1408-1415
pubmed: 29089129
Allergy. 2015 Jun;70(6):653-60
pubmed: 25753462
J Allergy Clin Immunol. 2015 Jul;136(1):3-13
pubmed: 26145982
Environ Health Perspect. 2018 Jul 17;126(7):077005
pubmed: 30024382
J Am Acad Dermatol. 2016 Dec;75(6):1119-1125.e1
pubmed: 27542586
BMJ Open. 2018 Sep 10;8(9):e021311
pubmed: 30206078
Environ Health Perspect. 2015 Sep;123(9):902-8
pubmed: 25826816
Int J Environ Res Public Health. 2009 Mar;6(3):1282-97
pubmed: 19440446
Int J Androl. 2010 Apr;33(2):333-45
pubmed: 20059582
Chemosphere. 2016 Jun;152:459-67
pubmed: 27003368
Allergy. 2015 Aug;70(8):973-84
pubmed: 25932997
Pediatr Pulmonol. 2004 Jun;37(6):492-8
pubmed: 15114549
Int J Epidemiol. 2016 Apr;45(2):382-8
pubmed: 27063603
Int J Epidemiol. 2017 Oct 1;46(5):1392-1393k
pubmed: 29040580
Arch Dis Child. 1999 Sep;81(3):225-30
pubmed: 10451395
Epidemiology. 1996 Nov;7(6):578-82
pubmed: 8899382
Philos Trans R Soc Lond B Biol Sci. 2009 Jul 27;364(1526):2097-113
pubmed: 19528058
Occup Environ Med. 2009 Oct;66(10):679-84
pubmed: 19770354
Int J Epidemiol. 2013 Aug;42(4):978-91
pubmed: 23064411
Environ Health Perspect. 2016 Dec;124(12):1848-1856
pubmed: 27219331
J Allergy Clin Immunol. 2015 Feb;135(2):370-8
pubmed: 25445825
ScientificWorldJournal. 2012;2012:542983
pubmed: 22927783
World Allergy Organ J. 2013 Dec 04;6(1):21
pubmed: 24304599
Int J Epidemiol. 2016 Apr;45(2):353-63
pubmed: 26283636

Auteurs

Berit Granum (B)

Norwegian Institute of Public Health, Oslo, Norway. Electronic address: berit.granum@fhi.no.

Bente Oftedal (B)

Norwegian Institute of Public Health, Oslo, Norway.

Lydiane Agier (L)

Team of Environmental Epidemiology, IAB, Institute for Advanced Biosciences, Inserm, CNRS, CHU-Grenoble-Alpes, University Grenoble-Alpes, Grenoble, France.

Valerie Siroux (V)

Team of Environmental Epidemiology, IAB, Institute for Advanced Biosciences, Inserm, CNRS, CHU-Grenoble-Alpes, University Grenoble-Alpes, Grenoble, France.

Philippa Bird (P)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford UK.

Maribel Casas (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Charline Warembourg (C)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

John Wright (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford UK.

Leda Chatzi (L)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA; Department of Social Medicine, University of Crete, Greece; Department of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.

Montserrat de Castro (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

David Donaire (D)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Regina Grazuleviciene (R)

Department of Environmental Sciences, Vytauto Didziojo Universitetas, Kaunas, Lithuania.

Line Småstuen Haug (L)

Norwegian Institute of Public Health, Oslo, Norway.

Lea Maitre (L)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Oliver Robinson (O)

ISGlobal, Barcelona, Spain; MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.

Ibon Tamayo-Uria (I)

ISGlobal, Barcelona, Spain.

Jose Urquiza (J)

ISGlobal, Barcelona, Spain.

Mark Nieuwenhuijsen (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Remy Slama (R)

Team of Environmental Epidemiology, IAB, Institute for Advanced Biosciences, Inserm, CNRS, CHU-Grenoble-Alpes, University Grenoble-Alpes, Grenoble, France.

Cathrine Thomsen (C)

Norwegian Institute of Public Health, Oslo, Norway.

Martine Vrijheid (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH